| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 772,861 | 19,043,000 | 8.96% | ||
| 2 | NEOGENOMICS INC | 2,737,943 | 14,812,000 | 6.97% | ||
| 3 | AKORN INC | 280,098 | 12,229,000 | 5.76% | ||
| 4 | RTI SURGICAL HOLDINGS INC COM | 1,713,376 | 11,068,000 | 5.21% | ||
| 5 | HARVARD BIOSCIENCE INC | 1,708,022 | 9,736,000 | 4.58% | ||
| 6 | AMAG PHARMACEUTICALS INC COM | 113,368 | 7,829,000 | 3.68% | ||
| 7 | NXSTAGE MED INC COM | 450,958 | 6,442,000 | 3.03% | ||
| 8 | Oxford Immunotec Global PLC | 448,365 | 6,210,000 | 2.92% | ||
| 9 | ARRAY BIOPHARMA INC COM | 849,374 | 6,124,000 | 2.88% | ||
| 10 | TEARLAB CORP | 3,017,872 | 6,096,000 | 2.87% | ||
| 11 | SPECTRANETICS CORP | 249,187 | 5,734,000 | 2.70% | ||
| 12 | INSMED INC COM PAR .01 | 231,471 | 5,653,000 | 2.66% | ||
| 13 | IGI LABS INC | 880,961 | 5,550,000 | 2.61% | ||
| 14 | OMNICELL COM COM | 146,921 | 5,540,000 | 2.61% | ||
| 15 | VERACYTE INC | 482,263 | 5,372,000 | 2.53% | ||
| 16 | LHC GROUP INC COM | 131,467 | 5,029,000 | 2.37% | ||
| 17 | LIGAND PHARMACEUTICALS INC | 49,115 | 4,956,000 | 2.33% | ||
| 18 | CELLDEX THERAPEUTICS INC NEW | 185,333 | 4,674,000 | 2.20% | ||
| 19 | ENDOLOGIX INC | 304,602 | 4,673,000 | 2.20% | ||
| 20 | BIO TECHNE CORP | 46,921 | 4,620,000 | 2.17% | ||
| 21 | ENZO BIOCHEM INC | 1,439,330 | 4,361,000 | 2.05% | ||
| 22 | CYNAPSUS THERAPEUTICS INC | 258,606 | 4,213,000 | 1.98% | ||
| 23 | QUIDEL CORP COM | 172,668 | 3,963,000 | 1.87% | ||
| 24 | ANGIODYNAMICS INC | 236,692 | 3,882,000 | 1.83% | ||
| 25 | LEMAITRE VASCULAR INC COM | 320,768 | 3,868,000 | 1.82% | ||
| 26 | ALKERMES PLC SHS | 54,533 | 3,509,000 | 1.65% | ||
| 27 | CEPHEID | 54,691 | 3,344,000 | 1.57% | ||
| 28 | HEALTHSTREAM INC COM | 100,754 | 3,065,000 | 1.44% | ||
| 29 | STREAMLINE HEALTH SOLUTIONS COM | 1,087,428 | 3,045,000 | 1.43% | ||
| 30 | VERTEX PHARMACEUT | 21,098 | 2,605,000 | 1.23% | ||
| 31 | FLUIDIGM CORP DEL COM | 98,209 | 2,377,000 | 1.12% | ||
| 32 | BIOMARIN | 16,365 | 2,238,000 | 1.05% | ||
| 33 | BLUEBIRD BIO INCORPORATED | 11,609 | 1,955,000 | 0.92% | ||
| 34 | SUNOPTA INC | 161,690 | 1,735,000 | 0.82% | ||
| 35 | VERASTEM INC COM | 228,538 | 1,723,000 | 0.81% | ||
| 36 | Esperion Therapeutics Inc | 19,930 | 1,629,000 | 0.77% | ||
| 37 | CYTOKINETICS INC | 218,792 | 1,470,000 | 0.69% | ||
| 38 | ARATANA THERAPEUTICS INC COM | 70,620 | 1,068,000 | 0.50% | ||
| 39 | HUMANA | 3,540 | 677,000 | 0.32% | ||
| 40 | ANTHEM INC | 4,095 | 672,000 | 0.32% | ||
| 41 | AETNA INC NEW | 5,215 | 665,000 | 0.31% | ||
| 42 | UNITED THERAPEUTICS | 3,820 | 664,000 | 0.31% | ||
| 43 | MYLAN N V | 9,775 | 663,000 | 0.31% | ||
| 44 | ENDO INTL | 8,161 | 650,000 | 0.31% | ||
| 45 | ALLERGAN PLC | 2,035 | 618,000 | 0.29% | ||
| 46 | NOVARTIS A G | 6,070 | 597,000 | 0.28% | ||
| 47 | BRISTOL MYERS SQUIBB CO | 8,290 | 552,000 | 0.26% | ||
| 48 | CELGENE CORP | 4,280 | 495,000 | 0.23% | ||
| 49 | BECTON DICKINSON & CO | 3,395 | 481,000 | 0.23% | ||
| 50 | LILLY ELI & CO | 5,495 | 459,000 | 0.22% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-002552, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
